AI智能总结
The selling stockholders identified in this prospectus supplement are offering 5,289,784 shares of our common stock. We are notselling any shares under this prospectus supplement and will not receive any proceeds from the sale of shares by the sellingstockholders. Our common stock is listed on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “FWRG.” OnNovember5, 2025, the last sale price of our common stock as reported on Nasdaq was $17.94 per share. Investing in our common stock involves risk. See “Risk Factors” on pageS-9of this prospectus supplement to read aboutfactors you should consider before buying shares of our common stock. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved ordisapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful orcomplete. Any representation to the contrary is a criminal offense. The underwriter has agreed to purchase our common stock from the selling stockholders at a price of $17.71416 per share, whichwill result in approximately $93.7 million of proceeds to the selling stockholders before expenses. The selling stockholders willreceive all of the proceeds from this offering. The underwriter may offer the shares of common stock from time to time for sale in one or more transactions on Nasdaq, in theover-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices relatedto prevailing market prices or at negotiated prices. See “Underwriting” for additional information regarding underwriter compensation. The underwriter expects to deliver the shares of common stock against payment in New York, New York on November 7, 2025. Citigroup The date of this prospectus supplement is November 5, 2025. TABLE OF CONTENTS Prospectus Supplement ABOUT THIS PROSPECTUS SUPPLEMENTPROSPECTUS SUPPLEMENT SUMMARYTHE OFFERINGWHERE YOU CAN FIND MORE INFORMATION;INCORPORATION OF CERTAIN DOCUMENTS BYREFERENCECAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSRISK FACTORSUSE OF PROCEEDSSELLING STOCKHOLDERSMATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FORNON-U.S.HOLDERSUNDERWRITINGLEGAL MATTERSEXPERTS Prospectus ABOUT THIS PROSPECTUSWHERE YOU CAN FIND MORE INFORMATION;INCORPORATION OF CERTAIN DOCUMENTS BYREFERENCECAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSTHE COMPANYRISK FACTORSUSE OF PROCEEDSDESCRIPTION OF CAPITAL STOCKSELLING STOCKHOLDERSPLAN OF DISTRIBUTIONLEGAL MATTERSEXPERTS Neither we, the selling stockholders nor the underwriter, have authorized anyone to provide any information or to make anyrepresentations other than those contained or incorporated by reference in this prospectus supplement, the accompanying prospectus orin any free writing prospectuses thereto that we have prepared. Neither we, the selling stockholders nor the underwriter, takeresponsibility for, or provide any assurance as to the reliability of, any other information that others may give you. This prospectussupplement is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to doso. The information contained in this prospectus supplement is current only as of its date. Our business, financial condition, results ofoperation and prospects may have changed since that date. ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement and the accompanying prospectus are part of a registration statement on Form S-3 that we filed withthe SEC utilizing a “shelf” registration process. This document is in two parts. The first part is this prospectus supplement, whichdescribes the specific terms of this common stock offering and also adds to and updates information contained in the accompanyingprospectus and the documents incorporated by reference therein. The second part, the accompanying prospectus, provides moregeneral information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. We urgeyou to carefully read this prospectus supplement and the accompanying prospectus, and the documents incorporated by referenceherein and therein, before buying any of the securities being offered under this prospectus supplement. To the extent that any statementthat we make in this prospectus supplement is inconsistent with statements made in the accompanying prospectus or any documentsincorporated by reference therein, the statements made in this prospectus supplement will be deemed to modify or supersede thosestatements made in the accompanying prospectus and documents incorporated by reference therein. This prospectus supplement, theaccompanying prospectus and the documents incorporated by reference include important information about us, the securities beingoffered and other information you should know before investing in our securities. You should also read and consider information in thedocuments to which we have refe